From: Impact of delays in radiotherapy of head and neck cancer on outcome
| Characteristics | No. (%) |
|---|---|
| Gender | |
| Female | 35 (13.2%) |
| Male | 227 (86.8%) |
| Age (years)a) | 60.6 ± 9.9 (38.9–89.3) |
| Tumor locationb) | |
| Oral cavity | 15 (5.5%) |
| Oropharynx | 133 (48.7%) |
| Hypopharynx | 53 (19.4%) |
| Larynx | 72 (26.4%) |
| Tumor stageb) | |
| Stage I | 12 (4.4%) |
| Stage II | 50 (18.3%) |
| Stage III | 48 (17.6%) |
| Stage IV | 163 (59.7%) |
| Treatmentb) | |
| Radiotherapy | 157 (57.5%) |
| Concurrent chemoradiotherapy | 116 (42.5%) |
| RT duration (days)a) | 50.2 ± 6.7 (35–80) |
| Time to treatment interventiona) | 35.6 ± 14.9 (7–90) |